Abstract
Objective: To explore the evidence around clozapine re-challenge following myocarditis. Conclusion: This case adds to the 17 cases of clozapine re-challenge following myocarditis, of which 71% were successful (12 cases). This demonstrates that re-challenge could be performed safely and effectively in the context of clozapine-induced myocarditis, if accompanied by a strict and rigorous monitoring protocol.
Original language | English |
---|---|
Pages (from-to) | 385-386 |
Number of pages | 2 |
Journal | Australasian Psychiatry |
Volume | 25 |
Issue number | 4 |
Early online date | 15 May 2017 |
DOIs | |
Publication status | Published - 1 Aug 2017 |
Keywords
- clozapine
- myocarditis
- re-challenge